CD274 and breast cancer: The profile of tumor infiltrating lymphocytes (TILs) and the immune checkpoint inhibitor PD-L1 was examined in head and neck squamous cell carcinoma (HNSCC), breast cancer (BCa), and non-small cell lung cancer (NSCLC) specimens obtained from primary surgical resections.